Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

Clinical Endocrinology

Volumn 52, Issue 5, 2000, Pages 543-548

  Kvasnička, Jan ^a   Marek, Josef ^a   Kvasnička, Tomáš ^a   Weiss, Vladimír ^a   Marková, Markéta ^a   Štěpán, Jan ^a   Umlaufová, Anna ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CELL ADHESION MOLECULE; FIBRINOGEN; GROWTH HORMONE; OROSOMUCOID; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT GROWTH HORMONE;

ADULT; ANTHROPOMETRY; ARTICLE; ATHEROGENESIS; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL;

ADULT; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; E-SELECTIN; FEMALE; FIBRINOGEN; GROWTH HORMONE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OROSOMUCOID; P-SELECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 0034082939     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01002.x     Document Type: Article

References (43)

1. al-Shoumer, K.A., Cox, K.H., Hughes, C.L., Richmond, W. & Johnston, D.G. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. Journal of Clinical Endocrinology and Metabolism, 82, 2653-2659.
2. Baumann, H. & Gauldie, J. (1994) The acute phase response. Immunology Today, 15, 74-80.
3. Benedek, I.H., Blouin, R.A. & McNamara, P.J. (1984) Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. British Journal of Clinical Pharmacology, 18, 941-946.
4. Bengtsson, B.A. (1996) Growth hormone deficiency in adults: a new indication for recombinant human growth hormone. Journal of Internal Medicine, 239, 283-286.
5. Bülow, B., Hagmar, L., Mikoczy, Z., Nordstrom, C.H. & Erfurth, E.M. (1997) Increased cerebral mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75-81.
6. Christopher, M., Hew, F.L., Oakley, M., Rantzau, C. & Alford, F. (1998) Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. Journal of Clinical Endocrinology & Metabolism, 83, 1668-1681.
7. Cummings, M.H., Christ, E., Umpleby, A.M., Albany, E., Wierzbicki, A., Lumb, P.J., Sonksen, P.H. & Russel-Jones, D.L. (1997) Abnormalities of very low density lipoprotein apolipoprotein B100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 2010-2013.
8. Cuneo, R.C., Judd, S., Wallace, J.D., Perry-Keene, D., Burger, H., Lim-Tio, S., Strauss, B., Stockigt, J., Topliss, D., Alford, F., Hew, L., Bode, H., Conway, A., Handelsman, D., Dunn, S., Boyages, S., Cheung, N.W. & Hurley, D. (1998) The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 83, 107-116.
9. Demling, R. (1999) Growth hormone therapy in critically ill patients. New England Journal of Medicine, 341, 837-839.
10. Dubost, J.J., Soubrier, M., Meunier, M.N. & Sauvezie, B. (1994) From erythrocyte sedimentation rate to profiles of acute phase proteins. Revue de Medecine Interne, 15, 727-733.
11. Galdiero, M., Donnarumma, G., Cipollaro de l'Ero, G., Marcatili, A., Scarfogliero, P., &. Sommese, L. (1995) Effect of growth hormone, prolactin and insulin on the release of IL-1 alpha, IFN-gamma and 1L-4 by staphylococcal enterotoxin A-stimulated splenocytes. European Cytokine Network, 6, 187-194.
12. Garry, P., Collins, P. & Devlin, J.G. (1996) An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. European Journal of Endocrinology, 134, 61-66.
13. Haeffner, A., Thieblemont, N., Deas, O., Marelli, O., Charpentier, B., Senik, A., Wright, S.D., Haeffner-Cavaillon, N. & Hirsch, F. (1997) Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappa B translocation in lipopolysaccharide stimulated human monocytes. Journal of Immunology, 158, 1310-1314.
14. Harpel, P.C., Hermann, A., Zhang, X., Ostfeld, I. & Borth, W. (1995) Lipoprotein (a), plasmin modulation and atherogenesis. Thrombosis and Haemostasis, 74, 382-386.
15. Held, C., Hjemdahl, P., Rehnqvist, N., Wallen, N.H., Forslund, L., Bjorkander, I., Angelin, B. & Wiman, B. (1997) Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls. Journal of Internal Medicine, 241, 59-69.
16. Hew, F.L., Koschmann, M., Christopher, M., Rantzau, C., Vaag, A., Ward, G., Beck-Nielsen, H. & Alford, F. (1996) Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. Journal of Clinical Endocrinology and Metabolism, 81, 555-564.
17. Jarrar, D., Wolf, S.E., Jeschke, M.G., Ramirez, R.J., DebRoy, M., Ogle, C.K., Papaconstaninou, J. & Herndon, D.N. (1997) Growth hormone attenuates the acute-phase response to thermal injury. Archives of Surgery, 132, 1171-1175.
18. Johansson, J.O., Landin, K., Tengborn, L., Rosen, T. & Bengtsson, B.A. (1994) High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arteriosclerosis Thrombosis and Vascular Biology, 14, 434-437.
19. Johansson, J.O., Landin, K., Johansson, G., Tengborn, L. & Bengtsson, B.A. (1996) Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thrombosis and Haemostasis, 76, 422-428.
20. Kahn, C.R. (1995) Causes of insulin resistance. Nature, 373, 384-385.
21. Keller, U. & Miles, J.M. (1991) Growth hormone and lipids. Hormone Research, 36 (Suppl.1), 36-40.
22. Lindberg, G., Rastam, L., Nilsson-Ehle, P., Lundblad, A., Ranstam, J., Folsom, A.R. & Burke, GL. (1999) Serum sialic acid and sialoglycoproteins in asymptomatic carotid artery atherosclerosis. ARIC Investigators. Atherosclerosis Risk in Communities. Atherosclerosis, 146, 65-69.
23. Mantovani, A., Sozzani, S., Vecchi, A., Introna, M. & Allavena, P. (1997a) Cytokine activation of endothelial cells: new molecules for an old paradigm. Thrombosis and Haemostasis, 78, 406-414.
24. Mantovani, A., Bussolino, F. & Introna, M. (1997b) Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunology Today, 18, 231-240.
25. Markussis, V., Beshyah, S.A., Fisher, C., Sharp. P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
26. May, J.M. & Ghosh, S. (1998) Signal transduction through NF-kappa B. Immunology Today, 19, 80-88.
27. McIntyre, T.M., Modur, V., Prescott, S.M. & Zimmerman, G.A. (1997) Molecular mechanisms of early inflammation. Thrombosis and Haemostasis, 78, 302-305.
28. Mejdoubi, N., Henriques, C., Bui, E., Durand, G., Lardeux, B. & Porquet, D. (1999) Growth hormone inhibits rat liver alpha-1-acid glycoprotein gene expression in vivo and in vitro. Hepatology, 29, 186-194.
29. Nolte, W., Radisch, C., Armstrong, V.W., Hufner, M. & von zur Muhlen, A. (1997) The effect of recombinant human GH replacement therapy on lipoprotein (a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo controlled trial. European Journal of Endocrinology, 137, 459-466.
30. O'Neal, D., Hew, F.L., Sikaris, K., Ward, G., Alford, F. & Best, J.D. (1996) Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. Journal of Clinical Endocrinology and Metabolism, 81, 2448-2454.
31. Oscarsson, J. & Ottosson, M., Johansson, J.O., Wiklund, O., Marin, P., Bjorntrop, P. &. Bengtsson, B.A. (1996) Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism, 45, 370-377.
32. Rekers-Mombarg, L.T., Rijkers, G.T., Massa, G.G. & Wit, J.M. (1995) Imunologic studies in children with idiopathic short stature before and during growth hormone therapy. Hormone Research, 44, 203-207.
33. Ridker, P.M. (1997) Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and haemostasis. Thrombosis and Haemostasis, 78, 53-59.
34. Ridker, P.M., Hennekens, C.H.H., Roitman-Johnson, B., Stampfer, M.J. & Allen, J. (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men. Lancet, 351, 88-92.
35. Rosén, T. & Bengtsson, B.A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
36. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
37. Sacca, L. (1997) GH deficiency and vascular disease: in search of linking mechanism. European Journal of Endocrinology, 136, 148-149.
38. Samad, F., Uysal, K.T., Wiesbrock, S.M., Pandey, M., Hotamisligil, G.S. & Loskutoff, D.J. (1999) Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proceedings of the National Academy of Science, USA, 96, 6902-6907.
39. Serri, O., St-Jacques, P., Sartippour, M. & Renier, G. (1999) Alteration of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. Journal of Clinical Endocrinology and Metabolism, 84, 58-63.
40. Steel, D.M. & Whitehead, A.S. (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today, 15, 81-88.
41. Takala, J., Ruokonen, E., Webster, N.R., Nielsen, M.S., Zandstra, D.F., Vundelinckx, G. & Hinds, CJ. (1999) Increased mortality associated with growth hormone treatment in critically ill adults. New England Journal of Medicine, 341, 785-792.
42. Vacková, I., Buzek, J. & Kvasnicka, J. (1991) Quantitative determination of C-reactive protein using the microturbidimetry method. Casopis Lékaru ceských, 130, 249-252.
43. Webster, J.M., Stewart, M., al-Maskari, M., Osman, I., Kendall-Taylor, P., Mitcheson, J. & Laker, M.F. (1997) The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein (a) in growth hormone-deficient adults. Atherosclerosis, 133, 115-121.